Showing results (241-250 of 402) with videos related to
Sort By:
Pageof 41
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
A 42-week open-label study to assess the pharmacokinetics, antiretroviral activity, and safety of amprenavir or amprenavir plus ritonavir in combination with abacavir and lamivudine for treatment of HIV-infected patientsRobin Wood, Joseph Eron, Keikawus Arasteh, et al.Tropical Medicine & International Health : TM & IH|September 15, 2012
The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failureMary-Ann Davies, Andrew Boulle, Karl Technau, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2013
CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South AfricaChristopher J Hoffmann, Michael Schomaker, Matthew P Fox, et al.Journal of the International AIDS Society|September 28, 2017
Twelve-year mortality in adults initiating antiretroviral therapy in South AfricaMorna Cornell, Leigh F Johnson, Robin Wood, et al.Antiviral Therapy|August 24, 2007
Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohortAndrew Boulle, Catherine Orrel, Richard Kaplan, et al.Plos One|November 16, 2013
Linkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South AfricaDarshini Govindasamy, Katharina Kranzer, Nienke van Schaik, et al.American Journal of Epidemiology|July 16, 2016
Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling AnalysisNadia N Abuelezam, Alethea W McCormick, Thomas Fussell, et al.Annals of the American Thoracic Society|February 21, 2026
Potential long-acting tuberculosis treatment for people with HIV: cost-effectiveness benchmarksAmy Zheng, Eden Pletner, Keren Middelkoop, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 26, 2010
Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaborationMary-Ann Davies, Harry Moultrie, Brian Eley, et al.Emerging Infectious Diseases|September 1, 2022
Improving Estimates of Social Contact Patterns for Airborne Transmission of Respiratory PathogensNicky McCreesh, Mbali Mohlamonyane, Anita Edwards, et al.Pageof 41